Adicet Bio, Inc. (ACET) Live Share Price, Invest From India

Adicet Bio, Inc. Stock Performance

as on March 21, 2026 at 6:59 am IST

Day's Low
Day's High
$6.83
Day's Price Range
$7.12
$6.92
1.30%
Downside
2.89%
Upside
52 Week's Low
52 Week's High
$6.41
52-Week Price Range
$17.44
$6.92
7.42%
Downside
152.00%
Upside

Adicet Bio, Inc. share price movements today

Previous Close: $7.07
Open: $6.97
Volume: 266.3K
Day's Low - High: $6.83 - $7.12
52 Week Low - High: $6.41 - $17.44

Adicet Bio, Inc. Historical Returns

1 Month Return: -3.08 %
3 Month Return: -12.4 %
1 Year Return: -43.55 %
3 Year Return: -93.42 %
5 Year Return: -97.03 %

Adicet Bio, Inc. Stock Fundamentals & Key Indicators

Check Adicet Bio, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$66.4M

EPS (TTM)

-9.862

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

0.82

EBITDA

-115.7M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

-67.55%

Adicet Bio, Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Adicet Bio, Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Adicet Bio, Inc.	BUY	$66.4M	-97.03%	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$41.3B	116.54%	133.52	8.45%
Vertex Pharmaceuticals Incorporated	BUY	$116.3B	110.08%	29.94	32.94%
Beone Medicines Ltd	NA	$32.5B	NA	114.93	5.37%
Regeneron Pharmaceuticals, Inc.	BUY	$78.0B	54.71%	17.8	31.41%

Stock Returns calculator for Adicet Bio, Inc. Stock including INR - Dollar returns

The Adicet Bio, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Adicet Bio, Inc. investment value today

Current value as on today

₹65,889

Returns

₹34,111

(-34.11%)

Returns from Adicet Bio, Inc. Stock

₹43,556 (-43.56%)

Dollar Returns*

₹9,445 (+9.44%)

Analyst Recommendation on Adicet Bio, Inc. Stock

Based on 15 analysts

BUY

80.00%

Buy

20.00%

Hold

0.00%

Sell

Based on 15 analysts, 80% of analysts recommend a 'BUY' rating for Adicet Bio, Inc.. Average target price of $56.83

Adicet Bio, Inc. Share Price Target

Get share price movements and forecasts by analysts on Adicet Bio, Inc..

What analysts predicted

87.82%UPSIDE

Target Price

$56.83

Current Price

$6.92

Analyzed by

15 Analysts

Target

$56.83

Adicet Bio, Inc. target price $56.83, a slight upside of 87.82% compared to current price of $6.92. According to 15 analysts rating.

Adicet Bio, Inc. Stock’s Investor Sentiment and Interest

Search interest for Adicet Bio, Inc. Stock has decreased by -1% in the last 30 days, reflecting a downward trend in search activity.

Time period: February 20, 2026 to March 22, 2026

Change:-1% versus previous 30 day period

Adicet Bio, Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Total Revenue	-	12	-	-	-	6	-	-	-	-
Gross Profit	-2	11	-1	-1	-1	3	-1	-1	-1	-1
Operating Income	-52	-31	-30	-32	-33	-30	-29	-32	-27	-31
EBITDA	-48	-27	-26	-28	-28	-27	-26	-29	-25	-34
Interest Expense	0	0	0	-	0	0	-	-	0	0
Depreciation	1	1	1	1	1	1	1	1	1	1
Income Before Tax	-49	-29	-28	-29	-30	-28	-28	-31	-26	-30
Income Tax Expense	0	1	1	-1	-	-	-	-	-	-
Net Income	-49	-29	-28	-29	-30	-28	-28	-31	-26	-30
Net Profit Margin	0.00%	-228.70%	0.00%	0.00%	0.00%	-441.55%	0.00%	0.00%	0.00%	0.00%

Adicet Bio, Inc. Annual Profit & Loss

All numbers in Millions USD

	Jun 2020	Dec 2020	Jun 2021	Dec 2021	Jun 2022	Dec 2022	Jun 2023	Dec 2023	Dec 2024	Dec 2025
Total Revenue	0	17	17	9	9	24	24	-	-	-
Gross Profit	-	17	-	9	-	24	-	-6	-6	-6
Operating Income	-	-39	-	-61	-	-72	-	-152	-127	-122
EBITDA	-	-37	-	-60	-	-64	-	-136	-110	-115
Interest Expense	-	0	-	0	-	0	-	0	0	0
Depreciation	-	1	-	1	-	2	-	6	6	6
Income Before Tax	-	-39	-	-62	-	-69	-	-142	-117	-116
Income Tax Expense	-	-2	-	0	-	-2	-	5	-	-
Net Income	-28	-36	-36	-61	-61	-69	-67	-142	-117	-116
Net Profit Margin	-2827.94%	-204.87%	-204.87%	-637.19%	-637.19%	-279.27%	-268.22%	0.00%	0.00%	0.00%

Adicet Bio, Inc. Quarterly Cash Flow

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Net Income	-29	-28	-29	-30	-28	-28	-31	-26	-30
Operating Cash Flow	-23	-22	-23	-22	-24	-25	-26	-22	-20
Investing Cash Flow	0	0	0	-96	-22	-2	32	16	-44
Financing Cash Flow	0	110	0	0	0	0	0	0	75
Change in Cash	-23	87	-23	-118	-46	-28	6	-5	9

Adicet Bio, Inc. Annual Cash Flow

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-33	-9	-28	-36	-61	-69	-142	-117	-116
Operating Cash Flow	-11	-18	-27	-41	-51	-44	-93	-92	-95
Investing Cash Flow	0	-16	-47	115	-2	-16	-4	-119	2
Financing Cash Flow	64	11	76	0	242	41	0	111	75
Change in Cash	30	-23	1	73	188	-20	-97	-100	-17

Global Institutional Holdings in Adicet Bio, Inc.

Funds	Holdings
Schonfeld Strategic Advisors LLC	2.26%
The Goldman Sachs Group Inc	2.44%
Renaissance Technologies Corp	2.53%
Stonepine Capital Management Llc	2.29%
NEXTBio Capital Management LP	1.64%

See all

Insights on Adicet Bio, Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 3 years, Adicet Bio, Inc. has experienced a drawdown of -92.8%, however Alnylam Pharmaceuticals, Inc. resisted the overall trend and outperformed by 90.3%
NO EFFECT
Against Peers
In the last 1 year, Regeneron Pharmaceuticals, Inc. has given 11.3% return, outperforming this stock by 54.8%
NEGATIVE IMPACT
Price Dip
In the last 3 years, ACET stock has moved down by -92.8%

About Adicet Bio, Inc.

adicet bio, inc. is a privately held, pre-clinical stage biotechnology company engaged in the design and development of cutting-edge immunotherapies with initial focus on cancer. adicet is developing novel universal immune cell therapies based on gamma delta t cells engineered with chimeric antigen receptors (cars) or t cell receptors (tcrs). adicet is also focused on identifying and validating cancer specific targets directed to the intracellular proteome and generating tcr-like mabs (tcrls) directed to these cancer-specific peptide targets presented by mhc class i complexes. these tcrls can be used to arm t cells, as t cell engagers or as antibody drug conjugates (adc). in august 2016, adicet entered a strategic collaboration with regeneron pharmaceuticals, inc. to develop next-generation engineered immune-cell therapeutics using adicet’s gamma delta t cell allogeneic platform technology. adicet bio raised $51m in series a financing led by orbimed partners, orbimed israel, novartis v

Organisation	Adicet Bio, Inc.
Headquarters	131 Dartmouth Street, Boston, MA, United States, 02116
Industry	Distribution Services
CEO	Mr. Chen Schor BA, CPA, M.B.A.
E-voting on shares	Click here to vote

Key Management of Adicet Bio, Inc.

Name	Title
Mr. Chen Schor BA, CPA, M.B.A.	CEO, President & Director
Mr. Brian Nicholas Harvey	Chief Financial Officer
Dr. Blake Aftab Ph.D.	Senior VP & Chief Scientific Officer
Dr. Donald Healey Ph.D.	Chief Technology Officer
Ms. Amy Locke	Chief Human Resource Officer
Dr. Julie Maltzman M.D.	Chief Medical Officer

FAQs

What is Adicet Bio, Inc. share price today?

Adicet Bio, Inc. share price today is $6.92 as on March 21, 2026 at 1:29 am IST at the close of the market. Adicet Bio, Inc. share today touched a day high of $7.12 and a low of $6.83.

What is the 52 week high and 52 week low for Adicet Bio, Inc. share?

Adicet Bio, Inc. share touched a 52 week high of $17.44 on October 13, 2025 and a 52 week low of $6.41 on February 5, 2026. Adicet Bio, Inc. stock price today i.e. March 21, 2026 at 1:29 am IST is closed at $6.92,which is 60.32% down from its 52 week high and 8.01% up from its 52 week low.

What is Adicet Bio, Inc.'s market capitalisation today?

Adicet Bio, Inc. market capitalisation is $0.00T as on March 21, 2026 at 1:29 am IST.

How to invest in Adicet Bio, Inc. Stock (ACET) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Adicet Bio, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Adicet Bio, Inc. Shares that will get you 0.2168 shares as per Adicet Bio, Inc. share price of $6.92 per share as on March 21, 2026 at 1:29 am IST.

What is the minimum amount required to buy Adicet Bio, Inc. Stock (ACET) from India?

Indian investors can start investing in Adicet Bio, Inc. (ACET) shares with as little as ₹93.652 or $1 (as of March 22, 2026 at 8:41 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹936.52 in Adicet Bio, Inc. stock (as per the Rupee-Dollar exchange rate as on March 22, 2026 at 8:41 pm IST). Based on Adicet Bio, Inc. share’s latest price of $6.92 as on March 21, 2026 at 1:29 am IST, you will get 1.4451 shares of Adicet Bio, Inc.. Learn more about fractional shares .

What are the returns that Adicet Bio, Inc. has given to Indian investors in the last 5 years?

Adicet Bio, Inc. stock has given -97.03% share price returns and 28.37% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?